Population-based incidence rates of cervical intraepithelial neoplasia in the human papillomavirus vaccine era

JAMA Oncology

Volumn 3, Issue 6, 2017, Pages 833-837

  Benard, Vicki B ^a   Castle, Philip E ^b   Jenison, Steven A ^c   Hunt, William C ^c   Kim, Jane J ^d   Cuzick, Jack ^e   Lee, Ji Hyun ^c   Du, Ruofei ^f   Robertson, Michael ^c   Norville, Scott ^c   Wheeler, Cosette M ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^f UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CERVICAL INTRAEPITHELIAL NEOPLASIA; EARLY CANCER DIAGNOSIS; FEMALE; HUMAN; INCIDENCE; NEW MEXICO; PAPILLOMAVIRUS INFECTIONS; REGISTER; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CERVICAL INTRAEPITHELIAL NEOPLASIA; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INCIDENCE; NEW MEXICO; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; REGISTRIES; YOUNG ADULT;

EID: 85011289157     PISSN: 23742437     EISSN: 23742445     Source Type: Journal    
DOI: 10.1001/jamaoncol.2016.3609     Document Type: Article

References (15)

1. Schiller JT, Castellsagué X, Villa LL, Hildesheim A. An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results. Vaccine. 2008; 26(suppl 10):K53-K61.
2. Kirby T. FDA approves new upgraded Gardasil 9. Lancet Oncol. 2015; 16(2):e56. doi:10.1016/S1470-2045(14)71191-X
3. Franco EL, Mahmud SM, Tota J, Ferenczy A., Coutlée F. The expected impact of HPV vaccination on the accuracy of cervical cancer screening: the need for a paradigm change. Arch Med Res. 2009; 40(6): 478-485.
4. Tota J, Mahmud SM, Ferenczy A, Coutlée F, Franco EL. Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era. Sex Health. 2010; 7(3): 376-382.
5. Cuzick J, Myers O, Hunt W.C., et al; New Mexico HPV Pap Registry Steering Committee. A population-based evaluation of cervical screening in the United States: 2008-2011. Cancer Epidemiol Biomarkers Prev. 2014; 23(5):765-773.
6. Centers for Disease Control and Prevention. Cervical cancer screening guidelines for average-risk women. http://www.cdc.gov/cancer/cervical/pdf/guidelines.pdf. Published 2015. Accessed August 24, 2016.
7. Surveillance, Epidemiology, and End Results. Trend algorithms. http://seer.cancer.gov/seerstat/WebHelp/seerstat.htm#Trend-Algorithms.htm. Accessed March 28, 2016.
8. Wickham H. ggplot2: Elegant Graphics for Data Analysis. New York, NY: Springer Science + Business Media; 2009.
9. Reagan-Steiner S., Yankey D, Jeyarajah J., et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years: United States, 2014. MMWR Morb Mortal Wkly Rep. 2015; 64(29):784-792.
10. Stokley S, Jeyarajah J, Yankey D., et al; Immunization Services Division, National Center for Immunization and Respiratory Diseases; Centers for Disease Control and Prevention. Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014: United States. MMWR Morb Mortal Wkly Rep. 2014; 63(29): 620-624.
11. Brotherton JM, Saville AM, May C.L., Chappell G., Gertig DM. Human papillomavirus vaccination is changing the epidemiology of high-grade cervical lesions in Australia. Cancer Causes Control. 2015; 26 (6):953-954.
12. Niccolai LM, Julian PJ, Meek J.I., McBride V., Hadler JL, Sosa LE. Declining rates of high-grade cervical lesions in young women in Connecticut, 2008-2011. Cancer Epidemiol Biomarkers Prev. 2013; 22(8):1446-1450.
13. Hariri S, Markowitz LE, Bennett N.M., et al; HPV-Impact Working Group. Monitoring effect of human papillomavirus vaccines in US population, Emerging Infections Program, 2008-2012. Emerg Infect Dis. 2015; 21(9):1557-1561.
14. Flagg EW, Datta SD, Saraiya M, et al Population-based surveillance for cervical cancer precursors in three central cancer registries, United States 2009. Cancer Causes Control. 2014; 25(5): 571-581.
15. Benard VB, Watson M, Castle P.E., Saraiya M. Cervical carcinoma rates among young females in the United States. Obstet Gynecol. 2012; 120(5): 1117-1123.